Prof Denis Migliorini (Geneva University Hospitals, Geneva, Switzerland) to discuss his presentation at the ESMO Immuno-Oncology Congress 2021 on the challenges of developing CAR-T therapies for brain tumours, and the future of this treatment in clinical practice.
Questions
1. What are the challenges of developing CAR-T therapies for solid tumours in general, and brain tumours in particular? 00:13-03:16
2. What strategies have been proposed to enhance the efficacy of CAR-T therapies in the treatment of brain tumours? 03:16-05:14
Speaker Disclosure: Denis Migliorini has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the ESMO Immuno-Oncology Congress 2021
